“Embryonic Re-Awakening” in Prostate Cancer; Can We Improve Treatments for Advanced Disease by Targeting Embryonic Pathways?

Speaker: Ralph Buttyan, PhD
Original Date: Tuesday, January 12, 2016

Learn from Dr. Ralph Buttyan, PhD, Professor, Urologic Sciences, University of British Columbia, about:

  • The parts of human embryonic development that become re-activated in prostate cancers that spread or are resistant to treatment
  • How this area of research is leading to novel therapeutic approaches to better control hormone resistant prostate cancer
  • The concept of the “prostate cancer stem cell” 

Dr. Ralph Buttyan's Biography:

Dr. Buttyan received graduate training leading to a PhD in Virology in 1980 at the University of Chicago. An avid bodybuilder at the time, he subsequently joined the Urology Department of Columbia University for Postdoctoral training on the role of androgenic steroids in prostate cancer progression and treatment. He advanced to Full Professor in Pathology and Urology at the site and was Co-Director of the Urologic Malignancies Program of the Herbert Irving Cancer Center. Dr Buttyan moved to Vancouver in 2011 to join the Vancouver Prostate Centre and he is a Professor in Urologic Sciences at the University of British Columbia. He is also the leader of the first Prostate Cancer Canada – Movember Team Grant that brings together investigators from across Canada in an effort to find better treatments for castration resistant prostate cancer. His personal research focuses on the developmental aspects of prostate cancer that drive therapeutic resistance and novel means to overcome the hormone resistant state. 

About Expert Angle

Expert AngleExpert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.


Prostate Cancer Awareness Month

Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.

Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.

Click here for news archive